Owing to its bulky, inflexible and hydrophobic tert-butyl side chain,
tert-leucine (Tle) finds increased use in templates or catalysts in as
ymmetric synthesis as well as in peptidic medicinal compounds. (S)-Tle
, available through a large-scale enzymatic reductive amination proces
s, has been incorporated into a variety of anti-AIDS and -cancer compo
unds. With two new routes to (R)-Tle coming available, the number of a
pplications of both (R)- and (S)-Tle can be expected to increase consi
derably.